Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer

13 Jan 2017

Abstract excerpt

Non-muscle invasive bladder cancer (NMIBC) patients frequently fail to respond to treatment and experience disease progression because of their clinical and biological diversity. In this study, we identify a prognostic molecular signature for predicting the heterogeneity of NMIBC by using an integrative analysis of copy number and gene expression data. We analyzed the copy number and gene expression profiles of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28082741
DOI: 10.1038/emm.2016.120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancerPMID 28082741Read ↗

Eight-gene risk score predicts progression and prognosis in bladder cancerSemantic proximity Read ↗

Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancerSemantic proximity Read ↗

Identification of muscle-invasive related genes in bladder cancer single-cell sequencing data for constructing patient prognostic modelSemantic proximity Read ↗

Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysisSemantic proximity Read ↗

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.Semantic proximity Read ↗

Risk Classification of Bladder Cancer by Gene Expression and Molecular SubtypeSemantic proximity Read ↗

A Four-Gene Signature Predicts Disease Progression in Muscle Invasive Bladder CancerSemantic proximity Read ↗

Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.Semantic proximity Read ↗

The consensus molecular classification of muscle-invasive bladder cancerSemantic proximity Read ↗

Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancerSemantic proximity Read ↗

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancerSemantic proximity Read ↗

Prognostic implications of a four-gene signature in non-muscle invasive bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.